| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976947 | Brachytherapy | 2015 | 5 Pages |
Abstract
With almost 4 years median followup, this study confirms previous data suggesting that PDR-BT is effective and safe in this indication. Local control rate and toxicity were in the range of what was seen with continuous low-dose-rate BT.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
W. Boukhelif, M. Ferri-Molina, R. Mazeron, P. Maroun, A.S. Duhamel-Oberlander, I. Dumas, F. Martinetti, A. Guemnie-Tafo, C. Chargari, C. Haie-Meder,